Please login to the form below
Agios Pharma
This page shows the latest Agios Pharma news and features for those working in and with pharma, biotech and healthcare.
Servier to acquire Agios’ oncology business in $1.8bn deal
French pharma will also gain Agios' oncology-associated employees. French pharma Servier has announced that it will acquire Agios Pharmaceuticals’ oncology business unit which includes it entire commercial, clinical and ... Agios already markets its
Latest news
-
Orphan drugs dominate FDA's record-breaking year
drugs, driven on by new pharma and biotech science, and the FDA's determination to accelerate its review times. ... There were also a number of drugs with brand new mechanisms of action, including three CGRP inhibitors for migraine prevention from Amgen,
-
Celgene, Agios get FDA OK for leukaemia drug Idhifa
Duo’s drug becomes first new AML therapy since Novartis' Rydapt. Celgene and Agios Pharma have claimed FDA approval for Idhifa, a new drug that is targeted at patients with a ... That kicked off in 2010 with a $130m upfront payment from Celgene to Agios
More from news
Approximately 0 fully matching, plus 3 partially matching documents found.
Latest appointments
-
Agios appoints Celgene’s Jackie Fouse
She joins the pharma group’s board of directors. Cancer and rare genetic disease focused group Agios Pharmaceuticals has appointed Jackie Fouse to its board of directors as the company prepares ... growing biotechnology company, so we are thrilled to
-
Chris Bowden joins Agios
He is former VP, product development oncology at Genentech. Agios Pharma has named former Genentech VP Chris Bowden as chief medical officer. ... Bowden's knowledge of oncology will benefit Agios as it prepares to advance the development of three
More from appointments
Approximately 1 fully matching, plus 1 partially matching documents found.
Subscribe to our email news alerts
- Strategy Director - Healthcare Advertising
- £90,000 - £120,000 yearly
- Early Access Program - Regulatory Affairs (EAP-RA)
- Highly competitive salary
-
Omnichannel Account Director
- £55,000 - £65,000 yearly
-
Pharmacovigilance Manager
- Highly competitive salary
-
Senior Medical Writer
- Highly competitive salary
- Associate Director - Global Healthcare Consulting
- £100,000 - £115,000 yearly
-
Pharmacovigilance Project Lead
- Highly competitive salary
-
Technical Sales Representative
- Highly competitive salary
- AstraZeneca/MSD’s Lynparza combination approved in UK for prostate cancer
- Eli Lilly increases investment to almost $1bn for new Irish manufacturing facility
- AbbVie’s Parkinson’s disease therapy application rejected by FDA
- FDA proposes improvements for oncology clinical trials supporting accelerated approval
- Italy accelerates the path towards digital therapeutics implementation
- AstraZeneca’s mild combination asthma reliever approved in UK
- Bristol Myers Squibb’s Sotyktu approved by EC for plaque psoriasis
- Positive results for Almirall’s lebrikizumab in atopic dermatitis published in NEJM and BJD
- When to call in the specialists: strategy in Medical Affairs
- Time to talk about health inequalities
- Powering Rapid Cognitive Analysis with AI
- AstraZeneca and Amgen’s Tezspire recommended by NICE for severe asthma
- Locus Biosciences announces first patient treated in urinary tract infection trial
- Team ITG appoints Gerhard Arnhofer as head of customer strategy for life sciences division
- AbbVie’s Parkinson’s disease therapy application rejected by FDA
- Results for Astellas’ non-hormonal menopause drug published in The Lancet
- Ketchum appoints Conor Nash as global chief financial officer and chief operating officer
- Kite reports positive three-year results for CAR T-cell therapy in rare blood cancer
PMHub
Envision Pharma Group
We are a global leader in the medical affairs space. Our purpose-built software and scientific solutions make us a unique...
Latest intelligence
- Time to talk about health inequalities
- Health inequalities are increasingly being recognised as a crucial healthcare challenge in the UK...
- The speed of science and the pace of comms
- Pharma red tape slows comms but there is a solution, Paul Hutchings, founder of fox&cat, writes....
- Improving cardiovascular disease care and awareness
- Scott Curley talks to PME about the risks of CVD and the importance of getting the right treatment at the right time...
